Francesca Bruce retweeted
German HTA: Clinical Cancer Registries Could Hold Key To Better Comparative Data For Benefit Assessments
bit.ly/3PlbCx6 #PinkSheet
Francesca Bruce retweeted
Take a look at our free-to-view @PharmaPinkSheet report by @ScripFrancesca on the finer points behind the @EMA_News review of @VertexPharma's cystic fibrosis combo Kaftrio. https://teapawt.org/t.co/uOfo7QNRYY
Francesca Bruce retweeted
BC province says it's leading Canada by promoting widespread biosimilar use. Re @JanssenGlobal's Remicade, @PharmaPinkSheet reports 5-10% use rate of biosimilar #infliximab in Canada after 4 years on market vs Norway (98%), UK (90%) & Scotland (85%). $$ https://teapawt.org/t.co/ePPFSIJxZt
Francesca Bruce retweeted
First application from a drug company for joint health economic assessment under new Swedish/Finnish/Norwegian pilot FINOSE expected soon, says TLV’s Niklas Hedberg #TOPRASym18
Francesca Bruce retweeted
EU parliamentary negotiations step up on controversial new regulation for member states to cooperate on HTA. Next vote scheduled for Oct 3. DG SANTE’s Flora Giorgio tells #TOPRASym18 she hopes the text will be finalised during this or the next parliament
Francesca Bruce retweeted
Europe's CMDh chair Laura Oliveira Santamaria urges industry to tell us the problems you face in meeting the Brexit deadline so we can find flexible solutions to avoid drug shortages #DIAEurope2018
Francesca Bruce retweeted
EMA tells me there's been a big response to its survey from companies on how they are preparing for Brexit. It has info on 90% of drugs subject to the survey; results will be published soon #DIAEurope2018
Francesca Bruce retweeted
Interesting session on experience with and lessons learned from EMA's 0070 clinical data publication more than one year after the transparency initiative went live #DIAEurope2018
Francesca Bruce retweeted
We need to mitigate medicines #shortages before they happen. Now we're managing them when they happen. That's too late. Maggie Dolan of NHS Commercial Solutions at #RAC18.
Francesca Bruce retweeted
2017 was very distressing year in UK in terms of #shortages of generic medicines. "Never seen anything like it," says Maggie Dolan of NHS Commercial Solutions at #RAC18.
Francesca Bruce retweeted
Getting senior @NICEcomms official on board @ABPI_UK is a major deal for the UK trade association. There's not a lot Carole Longson doesn't know about #HTA. #pharma teapawt.org/ABPI_UK/status/9565000…
"The appointment of Carole Longson to this new post signals our commitment to strengthening our focus on science, research and discovery in the UK" says #ABPI's chief executive Mike Thompson abpi.org.uk/media-centre/new…
Francesca Bruce retweeted
Minister Ananth Kumar says India will persuade docs to follow generic prescription rule and also propagate it
Francesca Bruce retweeted
Adaptive Pathways: A Solution For Worried #Payers in Europe 🔓 ➡
https://teapawt.org/t.co/ccnbg7ZjdF via @ScripRegNeena
Francesca Bruce retweeted
The #ScripAwards is free to enter and open to any research-based #pharmaceutical or #biotech company. scripawards.com
Francesca Bruce retweeted
📹 @ScripLucie speaks to Prexton Therapeutics CEO, Francois Conquet, about future for novel #Parkinsons therapy 🔓https://teapawt.org/t.co/TaKtJHT4DU
Francesca Bruce retweeted
Boehringer Menne scolds German government for latest AMVSG Act that hasn't ensured drug pricing that enables pharma R&D #BIAPC
Francesca Bruce retweeted
Mexico's COFEPRIS: A Friend Or Foe To Industry? https://teapawt.org/t.co/fG4nYJHUDL via @mcipriano93 #pharma
Francesca Bruce retweeted
Will #orphandrug #pricing come under more pressure over the next 5 years?
88%Yes
6%No
6%Don't know
17 votes • Final results Francesca Bruce retweeted
How Will #Pharma M&A Change In 2017? https://teapawt.org/t.co/L5P6I68yuC via @ScripLucie















